Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells

Por Ferguson, Peter J, DeMoor, Janice M, Vincent, Mark D, Koropatnick, James
Publicado em 2001

Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined “Complementary Lethality”

Por Rytelewski, Mateusz, Ferguson, Peter J, Vareki, Saman Maleki, Figueredo, Rene, Vincent, Mark, Koropatnick, James
Publicado em 2013

Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells

Por Ferguson, Peter J, Collins, Olga, Dean, Nicholas M, DeMoor, Janice, Sha-Li, Chen, Vincent, Mark D, Koropatnick, James
Publicado em 1999

Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin

Por Vareki, Saman Maleki, Rytelewski, Mateusz, Figueredo, Rene, Chen, Di, Ferguson, Peter J., Vincent, Mark, Min, Weiping, Zheng, Xiufen, Koropatnick, James
Publicado em 2014

siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine

Por Di Cresce, Christine, Figueredo, Rene, Rytelewski, Mateusz, Vareki, Saman Maleki, Way, Colin, Ferguson, Peter J., Vincent, Mark D., Koropatnick, James
Publicado no Oncotarget (2015)

IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells

Por Maleki Vareki, Saman, Chen, Di, Di Cresce, Christine, Ferguson, Peter J., Figueredo, Rene, Pampillo, Macarena, Rytelewski, Mateusz, Vincent, Mark, Min, Weiping, Zheng, Xiufen, Koropatnick, James
Publicado no PLoS One (2015)

Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2

Por Rytelewski, Mateusz, Vareki, Saman Maleki, Mangala, Lingegowda S., Romanow, Larissa, Jiang, Dahai, Pradeep, Sunila, Rodriguez-Aguayo, Christian, Lopez-Berestein, Gabriel, Figueredo, Rene, Ferguson, Peter J., Vincent, Mark, Sood, Anil K., Koropatnick, James D.
Publicado no Oncotarget (2016)

BRCA2 inhibition enhances cisplatin‐mediated alterations in tumor cell proliferation, metabolism, and metastasis

Por Rytelewski, Mateusz, Tong, Jessica G., Buensuceso, Adrian, Leong, Hon S., Maleki Vareki, Saman, Figueredo, Rene, Di Cresce, Christine, Wu, Sherry Y., Herbrich, Shelley M., Baggerly, Keith A., Romanow, Larissa, Shepherd, Trevor, Deroo, Bonnie J., Sood, Anil K., Chambers, Ann F., Vincent, Mark, Ferguson, Peter J., Koropatnick, James
Publicado no Mol Oncol (2014)